Review: Can Toxic Substances Initiate Psychotic Behavior? Part I. Antimalarial Drugs

Ilia Brondz

Norwegian Drug Control and Drug Discovery Institute (NDCDDI) AS, Ski, Norway.

DOI: 10.4236/ojpm.2014.47066                

Abstract

During and after every military conflict or war, there appears to be rapports about military crimes which were done by military and civil personal of conflicting sides. The basis of these offences is different; however the common to these is psychological and psychical background. The psychological background is an indoctrination of troopers that all what they are doing is right, well for country, nation or defends religion, or ideology. The life and property of enemy (opponent) are less worth than their oven. But most important in this indoctrination is the direct or indirect insurances about the absence of responsibility and promises about free for punishment for these actions. These aspects are well known and well-studied. The psychical background is less studied and more diverse; however in all cases the components of stress are present. The stress can be physical, psychical or toxic. The physical and psychical stress of engaged in military conflict personal is well studied, its action both during the war and as postwar syndrome have sufficient explanations. The action of intoxication especially by contaminants in medical forms, or toxins to induce the criminal behavior of military personal is nearly unstudied. The exceptions are alcohol, psychogenic substances as narcotics, LSD and special doping agents. This paper presented the evidences of additional toxic stress by contaminates in medical forms and intoxication by toxins of military personal engaged in different conflicts during last decades. The hypothesis about the influences of the additional toxic stress by medication with low quality pharmaceutical forms and some toxins on inducing the crimes generally and war crimes by military personal is launched in the paper. In this part the investigation will be concentrated on antimalarial drugs, especially on contaminated primaquine. Primaquine has a special position in preventing malaria infection in areas of conflict on the territories of endemic malaria. The possibility of induction of psychotic cases which lead to uncontrolled by person its-self actions and which are of criminal nature will be discussed, together with juridical responsibilities for these actions.

Keywords

Contaminated Medical Forms, Primaquine, Toxic Contaminants, Malaria, Toxic Stress Induced by Contaminated Medical Forms

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Brondz, I. (2011) Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine. Nova Science Publishers, Inc., New York.
[2]	Stürchler, D. (2001) Global Epidemiology of Malaria. In: Schlagenhauf-Lawlor, P., Ed., Travelers’ Malaria, BC Decker Inc., Hamilton, London, 14-55.
[3]	Russell, P.F. and Rozeboom, LE. (1943) Keys to the Anopheline Mosquitoes of the World. The American Entomological Society, The Academy of Natural Sciences, Philadelphia.
[4]	Coatney, G.R. and Getz, M.E. (1962) Primaquine and Quinocide as Curative Agents against Sporozoite-Induced Chesson Strain Vivax Malaria. Bulletin of the World Health Organization, 27, 290-293.
[5]	Elderfield, R.C., Gensler, W.J., Head, J.D., Hageman, H.A., Kremer, C.B., Wright, J.B., Holley, A.D., Williamson, B., Galbreath, J., Wielderhold, III, L., Flohardt, R., Kupchan, S.M., Williamson, T.A. and Birstein, O. (1946) Alkylaminoalkyl Derivatives of 8-Aminoquinoline. Journal of the American Chemical Society, 38, 1524-1528. http://dx.doi.org/10.1021/ja01212a040
[6]	Goodman, L.S. and Gilman, A. (1970) The Pharmacological Basis of Therapeutics. In: Goodman, L.S. and Gilman, A., Eds., A Textbook of Pharmacology, Toxicology, and Therapeutics for Physicians and Medical Students, 4th Edition, Coller-Macmillan Limited, London, Collier-Macmillan Canada Limited, Toronto, 1112-1115.
[7]	Brondz, I., Mantzeilas, D., Klein, U., Lebedeva, M.N., Mikhailitsyn, F.S. Souleimanov, G.D. andEkeberg, D. (2003) A 100 Years of Chromatography. 3rd International Symposium on Separation in BioSciences SBS 2003, Moscow, 13-18 May 2003, 165.
[8]	Brondz, I., Mantzilas, D., Klein, U., Ekeberg, D., Hvattum, E., Lebedeva, M.N., Mikhailitsyn, F.S., Souleimanov, G.D. and Røe, J. (2004) Nature of the Main Contaminant in the Anti-Malaria Drug Primaquine Di-Phosphate: A Qualitative Isomer Analysis. Chromatography B: Biomedical Sciences and Applications, 800, 211-223.
[9]	Brondz, I., Klein, U., Ekeberg, D., Mantzilas, D., Hvattum, E., Schultz, H. and Mikhailitsyn, F.S. (2004) Nature of the Main Contaminant in the Antimalaria Drug Primaquine Diphosphate: GC-MS Analysis. International Symposium Analytical Forum 2004, Warsaw, 4-8 July 2004, 119.
[10]	Brondz, I., Klein, U., Ekeberg, D., Mantzilas, D., Hvattum, E., Schultz, H. and Mikhailitsyn, F.S. (2005) Nature of the Main Contaminant in the Anti-Malaria Drug Primaquine Di-Phosphate: GC-MS Analysis. Asian Journal of Chemistry, 17, 1678-1688.
[11]	Brondz, I. and Klein, U. (2005) Separation of the Positional Isomer Quinocide from the Anti-Malarial Drug Primaquine Using a Discovery® HS F5 HPLC Column. The Reporter, 23, 1.
[12]	Brondz, I., Ekeberg, D., Karaliova, L., Jennings, I., Hustad, J.A. and Svendsen, R. (2005) Separation of the Positional Isomer Quinocide from the Anti-Malaria Drug Primaquine Using a Discovery® HS-F5 HPLC Column. Trends in Chromatography, 1, 78-81.
[13]	Brondz, I. and Klein, U. (2006) Separation of the Positional Isomer Quinocide from the Anti-Malarial Drug Primaquine Using a Discovery® HS F5 HPLC Column. The Reporter, 19, 3.
[14]	Brondz, I., Ekeberg, D., Bell, D.S., Hustad, J.A., Svendsen, R., Vlachos, V., Oakley, P.G., Langley, J., Mohini, T., Amaury, C.-G. and Mikhalitsyn, F. (2007) Nature of the Main Contaminant in the Drug Primaquine Diphosphate: SFC and SFC-MS Methods of Analysis. Journal of Pharmaceutical and Biomedical Analysis, 43, 937-944. http://dx.doi.org/10.1016/j.jpba.2006.09.017
[15]	Brondz, I., Ekeberg, D., Annino, A.R. and Palcic, T. (2007) SFC-MS Analyses of Anti-Malaria Drug Primaquine Diphosphate. Comparison of Techniques and Instrumentation. 12 Norwegian MS-Winter Meeting, Hafjell, 21-24 January 2007, 42.
[16]	Brondz, I., Fialkov, A.B. and Amirav, A. (2009) Analysis of Quinocide in Unprocessed Primaquine Diphosphate and Primaquine Diphosphate Tablets Using Gas Chromatography-Mass Spectrometry with Supersonic Molecular Beams. Journal of Chromatography A, 1216, 824-829. http://dx.doi.org/10.1016/j.chroma.2008.11.043
[17]	Brondz, I. (2009) Chapter 5, SFC-MS Analysis of Contaminants in Primaquine Diphosphate Tablets and Spectral UV and NMR Characterizing of Primaquine and Quinocide, In: Csizmadia, E. and Kalnoky, I., Eds., Antimalarial Drugs: Costs, Safety and Efficacy, Nova Science Publishers, Inc., New York, 105-124.
[18]	Brondz, I. (2009) Improved Separation of Quinocide in Primaquine Analysis by Supercritical Fluid Chromatography-Mass Spectrometry. 5th Conference Nordic Separation Science Society, Tallinn, 26-29 August 2009, abstr. PP06.
[19]	Brondz, I. (2009) SFC-MS Analysis of Contaminants in Primaquine Diphosphate Tablets and Spectral UV and NMR Characterizing of Primaquine and Quinocide. 5th Conference Nordic Separation Science Society, Tallinn, 26-29 August 2009, abstr. PP07.
[20]	Brondz, I. (2010) Chapter 6, Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine. In: Quintin, T.J., Ed., Chromatography: Types, Techniques and Methods, Nova Science Publishers, Inc., New York, 281-322.
[21]	Brondz, I. (2011) In Vitro Techniques in Analysis of Antimalarial Drug Primaquine (Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine. 7th Annual BioMalPar Conference on the Biology and Pathology of the Malaria Parasite, Heidelberg, 16-18 May 2011, abstr. 54, p. 80.
[22]	Brondz, I. and Brondz, A. (2012) The Technology for Preparation of Generic (Monoenantiomeric) Antimalarial Drug Primaquine by Using Supercritical Fluid Chromatography. Separation of Primaquine from Quinocide: Simultaneous Resolution of the Enantiomers of Primaquine and Their Separation from Quinocide in One Run. American Journal of Analytical Chemistry, 3, 884-890. http://dx.doi.org/10.4236/ajac.2012.312A117
[23]	Sin, D.D. and Shafran, S.D. (1996) Dapsone- and Primaquine-Induced Methemoglobinemia in HIV-Infected Individuals. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 12, 477-481. http://dx.doi.org/10.1097/00042560-199608150-00006
[24]	Coleman, M.D. and Coleman, N.A. (1996) Drug-Induced Methaemoglobinaemia. Treatment Issues. Drug Safety, 14, 394-405. http://dx.doi.org/10.2165/00002018-199614060-00005
[25]	Marrs, T.C., Bright, J.E. and Morris, B.C. (1987) Methemoglobinogenic Potential of Primaquine and Its Mutagenicity in the Ames Test. Toxicology Letters, 36, 281-287. http://dx.doi.org/10.1016/0378-4274(87)90197-4
[26]	Gareth, S. and Kantor, M.B. (1992) Primaquine-Induced Methemoglobinemia during Treatment of Pneumocystis carinii Pneumonia. The New England Journal of Medicine, 327, 1461. http://dx.doi.org/10.1056/NEJM199211123272016
[27]	Weed, R. (1961) Effects of Primaquine on the Red Blood Cell Membrane. II. K+ Permeability in Glucose-6-Phosphate Dehydrogenase Deficient Erythrocytes. Journal of Clinical Investigation, 40, 140-143. http://dx.doi.org/10.1172/JCI104227
[28]	Bullimore, D. (1993) The Role of Polyamines in Hepatic Encephalopathy and Cerebral Oedema. European Journal of Gastroenterology & Hepatology, 5, 63-67. http://dx.doi.org/10.1097/00042737-199302000-00001
[29]	Schmidt, I.G. and Schmidt, L.H. (1948) Neurotoxicity of the 8-Aminoquinolines. I. Lesions in the Central Nervous System of the Rhesus Monkey Induced by Administration of Plasmocid. Journal of Neuropathology & Experimental Neurology, 7, 368-398. http://dx.doi.org/10.1097/00005072-194810000-00002
[30]	Schmidt, I.G. and Schmidt, L.H. (1949) Neurotoxicity of the 8-Aminoquinolines. II. Reactions of Various Experimental Animals to Plasmocid. Journal of Comparative Neurology, 91, 337-367. http://dx.doi.org/10.1002/cne.900910303
[31]	Aarnoudse, A.L.H.J., van Schaik, R.H.N., Dieleman, J., Molokhia, M., van Riemsdijk, M.M., Ligthelm, R.J., Overbosch, D., van der Heiden, I.P. and Stricker, B.H.C. (2006) MDR1 Gene Polymorphisms Are Associated with Neuropsychiatric Adverse Effects of Mefloquine. Clinical Pharmacology & Therapeutics, 80, 367-374. http://dx.doi.org/10.1016/j.clpt.2006.07.003
[32]	Arasaki, K. and Nakanishi, T. (1989) Selective Neurotoxicity of Clioquinol on the Function of the Posterior Column Nuclei. Neuroscience Letters, 107, 85-88. http://dx.doi.org/10.1016/0304-3940(89)90795-7
[33]	Benazet, F. (1963) Pharmacology of 8-Aminoquinolines and Combinations of Various Synthetic Antimalarials. Médecine Tropicale: Revue du Corps de santé colonial, 23, 760-768.
[34]	Bernard, J., Le Camus, J., Sarrouy, J., Renaudineau, J., Calami, G., Trifot, M. and Martin, D. (1989) Toxic Encephalopathy Induced by Mefloquine: 3 Case Reports. Médecine et armées, 17, 209-211.
[35]	Björkman, A. (1989) Acute Psychosis Following Mefloquine Prophylaxis. The Lancet, 334, 865. http://dx.doi.org/10.1016/S0140-6736(89)93029-8
[36]	Caillon, E., Schmitt, L. and Moron, P. (1992) Acute Depressive Symptoms after Mefloquine Treatment. American Journal of Psychiatry, 149, 712.
[37]	Decourt, P. (1936) Studies of the Toxicity of Plasmochine and Rhodoquine. Bulletin de la Société de Pathologie Exotique, 29, 328-336.
[38]	Dow, G.S., Hudson, T.H., Vahey, M. and Koenig, M.L. (2003) The Acute Neurotoxicity of Mefloquine May Be Mediated through a Disruption of Calcium Homeostasis and ER Function in Vitro. Malaria Journal, 2, 14. http://dx.doi.org/10.1186/1475-2875-2-14
[39]	Dow, G., Bauman, R., Caridha, D., Cabezas, M., Du, F., Gomez-Lobo, R., Park, M., Smith, K. and Cannard, K. (2006) Mefloquine Induces Dose-Related Neurological Effects in a Rat Model. Antimicrobial Agents and Chemotherapy, 50, 1045-1053. http://dx.doi.org/10.1128/AAC.50.3.1045-1053.2006
[40]	Ferrier, T.M. and Eadie, M.J. (1973) Clioquinol Encephalopathy. Medical Journal of Australia, 2, 1008-1009.
[41]	Grupp, D., Rauber, A. and Fröscher, W. (1994) Neuropsychiatric Disturbances after Malaria Prophylaxis with Mefloquine. Aktuelle Neurologie, 21, 134-136. http://dx.doi.org/10.1055/s-2007-1017970
[42]	Hardgrove, M. and Applebaum, I.L. (1946) Plasmochin Toxicity: Analysis of 258 Cases. Annals of Internal Medicine, 25, 103-112. http://dx.doi.org/10.7326/0003-4819-25-1-103
[43]	Kaeser, H.E. (1984) Transient Global Amnesia Due to Clioquinol. Acta Neurologica Scandinavica, 100, 175-183.
[44]	Lapras, J., Vighetto, M., Trillet, A. and Garin, J.P. (1989) Transient Disorders of Memory after a Malaria Attack. Caused by Mefloquine? Presse Médicale, 18, 776.
[45]	Loken, A.C. and Haymaker, W. (1949) Pamaquine Poisoning in Man, with a Clinicopathologic Study of One Case. American Journal of Tropical Medicine and Hygiene, 29, 341-352.
[46]	Mawson, A. (2013) Mefloquine Use, Psychosis, and Violence: A Retinoid Toxicity Hypothesis. Medical Science Monitor, 19, 579-583. http://dx.doi.org/10.12659/MSM.889033
[47]	Lee, H.S. and Go, M.L. (1996) Effects of Mefloquine on Ca2+ Uptake and Release by Dog Brain Microsomes. Archives internationales de pharmacodynamie et de thérapie, 331, 221-231.
[48]	Patchen, L.C., Campbell, C.C. and Williams, S.B. (1989) Neurologic Reactions after a Therapeutic Dose of Mefloquine. The New England Journal of Medicine, 321, 1415-1416. http://dx.doi.org/10.1056/NEJM198911163212017
[49]	Schlagenhauf, P. and Steffen, R. (2000) Neuropsychiatric Events and Travel: Do Antimalarials Play a Role? Journal of Travel Medicine, 7, 225-226. http://dx.doi.org/10.2310/7060.2000.00069
[50]	Schmidt, I.G. (1947) Effects of Pamaquine on the Central Nervous System. Anatomical Record, 97, 367.
[51]	Schmidt, I.G. and Schmidt, L.H. (1947) Studies on the 8-Aminoquinolines; the Effects of Plasmocid on the Central Nervous System. Federation Proceedings, 6, 368.
[52]	Schmidt, I.G. and Schmidt, L.H. (1948) Neurotoxicity of the 8-Aminoquinolines. I. Lesions in the Central Nervous System of the Rhesus Monkey Induced by Administration of Plasmocid. Journal of Neuropathology & Experimental Neurology, 7, 368-398. http://dx.doi.org/10.1097/00005072-194810000-00002
[53]	Schmidt, I.G. and Schmidt, L.H. (1951) Neurotoxicity of the 8-Aminoquinolines. III. The Effects of Pentaquine, Isopentaquine, Primaquine, and Pamaquine on the Central Nervous System of the Rhesus Monkey. Journal of Neuropathology & Experimental Neurology, 10, 231-256. http://dx.doi.org/10.1097/00005072-195107000-00001
[54]	Schmidt, L.H. and Smith, C.C. (1947) Studies on the 8-Aminoquinolines; the Toxicities of Pamaquine and Plasmocid in Different Animal Species. Federation Proceedings, 6, 369.
[55]	Sipe, J.C., Vick, N.A., Schulman, S. and Fernandez, C. (1973) Plasmocid Encephalopathy in the Rhesus Monkey: A Study of Selective Vulnerability. Journal of Neuropathology & Experimental Neurology, 32, 446-457. http://dx.doi.org/10.1097/00005072-197307000-00009
[56]	Tateishi, J., Kuroda, S., Saito, A. and Otsuki, S. (1972) Neurotoxicity of Clioquinol in Laboratory Animals. The Lancet, 300, 1095. http://dx.doi.org/10.1016/S0140-6736(72)92392-6
[57]	Tsubaki, T., Honma, Y. and Hoshi, M. (1971) Neurological Syndrome Associated with Clioquinol. The Lancet, 1, 696-697. http://dx.doi.org/10.1016/S0140-6736(71)92699-7
[58]	Nevin, R.L. (2014) Idiosyncratic Quinoline Central Nervous System Toxicity: Historical Insights into the Chronic Neurological Sequelae of Mefloquine. International Journal for Parasitology: Drugs and Drug Resistance, 4, 118-125. http://dx.doi.org/10.1016/j.ijpddr.2014.03.002
[59]	Lee, C.C., Kinter, L.D. and Heiffer, M.H. (1981) Subacute Toxicity of Primaquine in Dogs, Monkeys, and Rats. Bulletin of the World Health Organisation, 59, 439-448.
[60]	Brondz, I. (2013) Editorial: Analytical Methods in Quality Control of Scientific Publications Part II the Authors’, Reviewers’, Editors’ Responsibility and the Publishers’ Authority. International Journal of Analytical Mass Spectrometry and Chromatography, 1, 81-89. http://dx.doi.org/10.4236/ijamsc.2013.12010